Profusa (PFSA) Non Operating Income (2022 - 2026)
Profusa's (PFSA) quarterly Non Operating Income came in at -$6.2 million in Q2 2026, down 361.71% on a YoY basis from $2.4 million in Q2 2025, and down 1229.09% quarter-over-quarter from $550000.0 in Q1 2026.
Analysis
Profusa (PFSA) Non Operating Income (2022 - 2026) Analysis & Trends
Profusa (PFSA) has reported Non Operating Income for 5 consecutive years, with -$6.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Income fell 361.71% year-over-year to -$6.2 million; the trailing twelve-month figure through Jun 2026 stood at -$11.1 million (down 114.19% YoY), and the FY2025 full-year result was -$8.1 million, down 71.61% from the prior year.
- Non Operating Income retreated to -$6.2 million in Q2 2026 per PFSA's latest filing, from $550000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $4.0 million in Q1 2022 and bottomed at -$6.2 million in Q2 2026.
- Historically, Non Operating Income has averaged -$262523.7 across 5 years, with a median of -$86539.5 in 2023.
- The sharpest annual moves came in 2024 and 2026: Non Operating Income slumped 2593.82% in 2024, then jumped 142.57% in 2026.
- Over 5 years, Non Operating Income stood at $1.3 million in 2022, then slumped by 45.24% to $722417.0 in 2023, then plunged by 261.96% to -$1.2 million in 2024, then plunged by 327.09% to -$5.0 million in 2025, then fell by 24.27% to -$6.2 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$6.2 million, $550000.0, and -$5.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Profusa | 141,306.20 | -577,693.80 | - | -6.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.21 Mn |
| Mar 31, 2026 | 550,000.00 |
| Dec 31, 2025 | -5.00 Mn |
| Sep 30, 2025 | -483,000.00 |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | -1.17 Mn |
| Sep 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -121,331.00 |
| Mar 31, 2024 | -327,982.00 |
| Dec 31, 2023 | 722,417.00 |
| Sep 30, 2023 | -51,748.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 3.95 Mn |